HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Magdalena Dmoszyńska-Graniczka Selected Research

cambinol

8/2021Antagonistic Interaction between Histone Deacetylase Inhibitor: Cambinol and Cisplatin-An Isobolographic Analysis in Breast Cancer In Vitro Models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Magdalena Dmoszyńska-Graniczka Research Topics

Disease

11Neoplasms (Cancer)
11/2021 - 08/2013
3Laryngeal Neoplasms (Laryngeal Cancer)
04/2020 - 11/2014
3Sarcoma (Soft Tissue Sarcoma)
01/2020 - 04/2019
3Carcinosarcoma
01/2020 - 04/2019
2Rhabdomyosarcoma
11/2021 - 04/2020
1Neuroblastoma
11/2021
1Breast Neoplasms (Breast Cancer)
08/2021
1Glioma (Gliomas)
11/2020
1Squamous Cell Carcinoma of Head and Neck
04/2020
1Leiomyosarcoma
01/2020
1Lung Neoplasms (Lung Cancer)
06/2019
1Endometrial Stromal Sarcoma
04/2019
1Adenocarcinoma of Lung
01/2016
1Carcinoma (Carcinomatosis)
01/2016
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2016
1Low Back Pain (Lumbago)
01/2015
1Pain (Aches)
01/2015
1Back Pain (Backache)
01/2015
1Medulloblastoma
11/2014

Drug/Important Bio-Agent (IBA)

3Cisplatin (Platino)FDA LinkGeneric
11/2021 - 01/2017
3xanthohumolIBA
11/2019 - 10/2015
2Phosphotransferases (Kinase)IBA
11/2021 - 01/2016
2Pharmaceutical PreparationsIBA
11/2021 - 01/2016
2betulinIBA
11/2021 - 11/2020
2TriterpenesIBA
11/2021 - 11/2020
2Histone Deacetylase InhibitorsIBA
08/2021 - 01/2017
2Bromodeoxyuridine (BrdU)IBA
11/2020 - 01/2016
2GemcitabineFDA Link
01/2020 - 12/2019
2fucoidanIBA
12/2019 - 04/2019
2Biological ProductsIBA
06/2019 - 10/2015
1PhytochemicalsIBA
11/2021
1Temozolomide (Temodar)FDA LinkGeneric
11/2021
1Cytostatic AgentsIBA
08/2021
1Estrogen ReceptorsIBA
08/2021
1cambinolIBA
08/2021
1DeoxyuridineIBA
11/2020
1Inosine Monophosphate (IMP)IBA
04/2020
1imperatorinIBA
04/2020
1Furocoumarins (Furanocoumarins)IBA
04/2020
1MTOR InhibitorsIBA
01/2020
1Antineoplastic Agents (Antineoplastics)IBA
01/2020
1Sirolimus (Rapamycin)FDA Link
01/2020
1sapanisertibIBA
01/2020
1Annexin A5IBA
06/2019
1Cytotoxins (Cytolysins)IBA
04/2019
1VorinostatFDA Link
01/2017
1BromidesIBA
01/2017
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2016
1Cyclin D1IBA
01/2016
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2016
1osthol (osthole)IBA
11/2014
1Histone Deacetylases (Histone Deacetylase)IBA
08/2013
1ChromatinIBA
08/2013
1Histones (Histone)IBA
08/2013

Therapy/Procedure

4Therapeutics
08/2021 - 11/2014
2Drug Therapy (Chemotherapy)
08/2021 - 04/2020
1Aftercare (After-Treatment)
11/2021
1Chemoprevention
11/2014